GenesisCare has more than 350 oncology centers around the world. The works have meant a great qualitative leap forward, equipping the Alcázar de San Juan center...
The six listed pharmaceutical companies close the first quarter of 2022 with a stock market value of $16.7 billion (€15.1 billion). The biggest decline was registered...
The Spanish company Exheus has recently opened a financing round in order to launch into the European market. The functioning of Exheus tests is based on...
Integra Therapeutics will allocate the funds to the development of the FiCAT platform prototype and preclinical validation. The Catalan company has also raised sufficient capital to...
The capital raised by Kither Biotech will be used to fund the development of Kither's lead product (Kit2014), a novel cell-permeable peptide for the treatment of...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...
Pfizer is the only company that has a pneumococcal vaccine in Spain with an indication from six weeks of age. The tender budget has been determined...
Miwendo receives funds from the European Union (EU) to advance in cancer detection. Colorectal cancer is the most prevalent cancer in Spain and, worldwide, 1.4 million...
In the fourth quarter of 2021, Moderna achieved a profit of $4.87 billion compared with a loss of $272 million in 2020. Total revenue increased from...
With the publication of the results of this trial, which will probably take place in March or April, Neurofix Pharma will increase its valuation and will...